During the last session, Mira Pharmaceuticals Inc (NASDAQ:MIRA)’s traded shares were 47.65 million, with the beta value of the company hitting 2.10. At the end of the trading day, the stock’s price was $1.07, reflecting an intraday gain of 19.26% or $0.17. The 52-week high for the MIRA share is $5.01, that puts it down -368.22 from that peak though still a striking 52.34% gain since the share price plummeted to a 52-week low of $0.51. The company’s market capitalization is $17.99M, and the average intraday trading volume over the past 10 days was 4.9 million shares, and the average trade volume was 253.70K shares over the past three months.

Mira Pharmaceuticals Inc (NASDAQ:MIRA) trade information

Mira Pharmaceuticals Inc (MIRA) registered a 19.26% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 19.26% in intraday trading to $1.07, hitting a weekly high. The stock’s 5-day price performance is 26.63%, and it has moved by -8.55% in 30 days. Based on these gigs, the overall price performance for the year is 28.92%. The short interest in Mira Pharmaceuticals Inc (NASDAQ:MIRA) is 0.57 million shares and it means that shorts have 1.57 day(s) to cover.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -224.25%. While earnings are projected to return 14.29% in 2025.

MIRA Dividends

Mira Pharmaceuticals Inc is due to release its next quarterly earnings on 2025-Mar-27. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Mira Pharmaceuticals Inc (NASDAQ:MIRA)’s Major holders

Mira Pharmaceuticals Inc insiders own 23.33% of total outstanding shares while institutional holders control 6.51%, with the float percentage being 8.49%.